Salmon lice are ectoparasitic copepods — small crustaceans that attach to the skin, fins, and mucus of Atlantic salmon and other salmonids. They feed on skin cells, mucus, and blood. Lepeophtheirus salmonis is the primary concern in Norwegian and Scottish waters; Caligus elongatus and Caligus rogercresseyi affect Atlantic salmon in Scottish and Chilean waters respectively.
Adult female lice can be up to 10mm long and are visible to the naked eye. They produce egg strings containing hundreds of eggs, which hatch as free-swimming copepodids that attach to passing fish. A salmon carrying heavy louse burdens — tens to hundreds of lice — faces significant tissue damage, immune suppression, and osmoregulatory disruption.
Salmon lice cause welfare harm through multiple pathways:
Welfare scoring systems for salmon now routinely include louse burden as a core indicator. The Norwegian salmon industry's Operational Welfare Indicators (OWIs) include louse count and wound severity scores assessed during routine handling.
Norway produces approximately 1.4 million tonnes of Atlantic salmon annually (58% of global production); Scotland produces 200,000 tonnes; Chile 1 million tonnes. The sea louse problem costs the global salmon industry an estimated USD $1 billion annually in treatments, losses, and management costs. In Norway, approximately 200 million doses of delousing treatments are administered annually, and treatment costs exceed NOK 10 billion per year.
Louse population monitoring is mandatory in Norway: producers must report weekly louse counts to the Norwegian Food Safety Authority. Regulatory thresholds (0.2 adult female lice per fish in sensitive periods) trigger mandatory treatment or fallowing.
Medicinal bath treatments (hydrogen peroxide, azamethiphos, deltamethrin) have been the primary treatment tools. These involve bathing fish in chemical solutions in enclosed well-boats or tarps. Welfare concerns include: treatment stress from crowding and chemical exposure, respiratory distress during treatment, and handling-related injuries. Hydrogen peroxide, in particular, causes significant stress and can cause mortality at suboptimal concentrations. Resistance to all currently used chemicals has developed in louse populations in all major producing regions.
Hydrolicer and thermolicer systems use water jets or warm water exposure to dislodge lice. Thermal (35°C warm water) lice removal is increasingly popular. Welfare research shows significant stress during thermal treatment: elevated cortisol and fin damage are documented. However, compared to repeated chemical treatment, mechanical systems are non-residual and may be preferable in some contexts.
Wrasse (particularly ballan wrasse and goldsinny wrasse) and lumpsucker fish are deployed in salmon cages as "cleaner fish" — they eat lice from salmon skin. This approach is both welfare-positive (non-chemical) and welfare-challenging: cleaner fish welfare has been largely neglected, with wrasse experiencing high mortality rates (up to 50% per production cycle) from predation, stress, and inadequate husbandry. In 2025, the Norwegian and Scottish industries are improving wrasse welfare standards: minimum size requirements, hiding structure provision, and species-appropriate feed are being implemented. Lumpsucker welfare requirements are also being developed.
Lice copepodids are surface-dwelling; salmon that spend less time at the surface are less exposed. Submerged feeding systems and snorkel barriers that prevent surface access have shown 60–80% reductions in lice infestation in Norwegian trials. These are prevention strategies requiring minimal treatment — good welfare outcomes through reduced lice burden and reduced treatment stress.
The ultimate lice solution is physical exclusion — raising salmon in closed containment aquaculture systems (land-based recirculating aquaculture systems, RAS) or offshore locations where copepodid densities are low. Norwegian authorities are incentivizing offshore systems through development licenses. RAS land-based salmon farming is expanding globally — salmon raised in closed RAS systems have essentially zero louse burden and are treated with no louse-control chemicals. Welfare in RAS depends critically on water quality management, but lice are eliminated as a welfare concern.
Selective breeding for louse resistance is underway at SalmoBreed and other Norwegian breeding companies. Genomic selection for reduced louse susceptibility is advancing — fish that mount faster immune responses to lice show reduced infestation levels. This genetic approach — improving disease resistance rather than treating disease — is a welfare-positive long-term strategy.
Norway's traffic light system (red/yellow/green zones based on louse pressure effects on wild salmonid migration) remains the primary regulatory driver, with red zones requiring production cuts of up to 6%. Scotland's Sea Lice Management Strategy (updated 2024) strengthened reporting requirements and introduced coordination areas for industry-wide louse management. Chile's SERNAPESCA enforces louse thresholds with escalating penalties for non-compliance.
Tags: Salmon Lice Aquaculture Fish Welfare Norway 2025